NCCN: Fever and neutropenia.
Wade
J C
JC
University of Texas, M. D. Anderson Cancer Center, USA.
Rubenstein
E B
EB
D000081:Acetamides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002406:Catheterization, Peripheral / Q000009:adverse effects; D005334:Fever / Q000209:etiology* / Q000382:microbiology; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D000069349:Linezolid; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000150:complications* / Q000209:etiology; D023303:Oxazolidinones / Q000627:therapeutic use; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome; D014769:Virginiamycin / Q000627:therapeutic use
D000081:Acetamides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000935:Antifungal Agents; D000970:Antineoplastic Agents; D023303:Oxazolidinones; D014769:Virginiamycin; C062940:quinupristin-dalfopristin; D000069349:Linezolid